Bone Diseases: Clinical Trials

101 trials for Bone Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

101 unknown. 101 Phase 2, 20 Phase 3, 18 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2101Unknown 101
Phase 320Unknown 20
Phase 118Unknown 18

Follow Bone Diseases: new trials by email Literature Review of Bone Diseases trials Research Report on Bone Diseases

Trials (filtered) newest first · largest first

All 101 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis
SCT650C - Axial Spondyloarthritis
Phase 2UnknownSinocelltech Ltd.1682024-07-012024-01-09
Vosoritide for Short Stature in Turner Syndrome
Vosoritide - Turner Syndrome, Short Stature
Phase 2UnknownRoopa Kanakatti Shankar, MBBS, MS202024-04-122024-06-24
A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS)
608 Dose A, 608 Dose B, 608 Dose C - Ankylosing Spondylitis
Phase 2UnknownSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.2502024-03-192024-10-23
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
HS-10374, HS-10374-matched placebo tablets, Tofacitinib 5Mg Tab,Oral - Psoriatic Arthritis
Phase 2UnknownHansoh BioMedical R&D Company1602024-02-262024-07-18
Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib
Baricitinib 2mg, Tofacitinib 5 mg - Spondyloarthritis, Axial
Phase 2UnknownBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1842023-10-302023-12-21
Radiographic Assessment of Bone Dimension Around Immediate Implants With FDBA and I-PRF vs FDBA Alone
i-PRF and FDBA - Bone Density Increased
Phase 2UnknownKrishnadevaraya College of Dental Sciences & Hospital202023-07-152024-07-30
Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis
400 IU, 5000 IU, 10000 IU - Spondylitis, Tuberculosis
Phase 2 / Phase 3UnknownHasanuddin University372022-07-012022-05-17
Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis
JMT103, Denosumab, Placebo - Postmenopausal Osteoporosis
Phase 2UnknownShanghai JMT-Bio Inc.2002022-04-212022-07-18
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Doxorubicin, Cisplatin, Methotrexate, Doxorubicin, Cisplatin - Osteosarcoma, Neoplasms, Connective Tissue
Phase 2 / Phase 3UnknownBlokhin's Russian Cancer Research Center502022-01-102024-04-01
Incobotulinumtoxin A and Yoga-like Isometric Exercise in Adolescent Idiopathic Lumbar Scoliosis
Botulinum toxin type A, Isometric Yoga-like exercise, Placebo - Scoliosis Idiopathic, Scoliosis; Adolescence
Phase 2UnknownManhattan Physical Medicine and Rehabilitation, LLP422021-07-012023-10-19
Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas
Trabectedin - Soft Tissue Sarcoma, Bone Tumors
Phase 2UnknownGrupo Espanol de Investigacion en Sarcomas852021-05-282023-03-27
Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction
EB-CMF - Mandible Tumor, Mandibular Injuries
Phase 1 / Phase 2UnknownEpibone, Inc.62021-03-312022-05-27
The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
Ozempic, Placebo - Osteopenia
Phase 1 / Phase 2UnknownMorten Frost642021-03-242021-03-30
Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD
Autologous BM-MSC, Sham - Intervertebral Disc Degeneration, Chronic Low-back Pain
Phase 2UnknownFondazione Policlinico Universitario Campus Bio-Medico522021-03-222025-05-25
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis
Phase 1 / Phase 2UnknownAll Natural Medicine Clinic, LLC20002021-03-012021-05-26
Safety Evaluation of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion
ART352-L - Degenerative Spondylolisthesis
Phase 1 / Phase 2UnknownAnkasa Regenerative Therapeutics, Inc.122020-09-302020-10-12
KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion
TGplPTH1-34 in fibrin, Autologous Bone Graft - Degenerative Disc Disease, Spinal Fusion
Phase 2UnknownKuros Biosurgery AG502020-08-272023-08-09
Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement
Tofacitinib 5 MG Oral Tablet [Xeljanz], Placebo oral tablet - Psoriatic Arthritis, Spondylitis
Phase 2UnknownCharite University, Berlin, Germany802020-08-042022-07-26
Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients
Mesenchymal Stem Cell - Osteoporosis
Phase 2UnknownAhmad Jabir Rahyussalim52020-08-012020-08-07
Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations
Infigratinib - Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase 2UnknownLianBio LLC802020-05-132022-06-27

Showing 20 of 101. Sign in to see all of them.

Narrower conditions

Osteoporosis (17)  ·  Spondylitis, Ankylosing (13)  ·  Bone Diseases, Metabolic (10)  ·  Intervertebral Disc Degeneration (9)  ·  Alveolar Bone Loss (6)  ·  Osteoporosis, Postmenopausal (6)  ·  Bone Neoplasms (5)  ·  Low Back Pain (5)  ·  Arthritis, Psoriatic (4)  ·  Axial Spondyloarthritis (4)  ·  Spondylarthritis (4)  ·  Spondylolisthesis (4)  ·  Dwarfism, Pituitary (3)  ·  Intervertebral Disc Displacement (3)  ·  Osteonecrosis (3)

Broader conditions

Musculoskeletal Diseases (99)  ·  Spinal Diseases (40)  ·  Joint Diseases (25)  ·  Metabolic Diseases (25)  ·  Nutritional and Metabolic Diseases (25)  ·  Arthritis (22)  ·  Spondylitis (22)  ·  Spondylarthropathies (21)  ·  Spondylarthritis (19)  ·  Pathological Conditions, Signs and Symptoms (18)  ·  Ankylosis (15)  ·  Bone Diseases, Metabolic (15)  ·  Bone Diseases, Developmental (13)  ·  Axial Spondyloarthritis (12)

Interventions

Etanercept (5)  ·  tofacitinib (4)  ·  Adalimumab (3)  ·  Alendronate (3)  ·  Cholecalciferol (3)  ·  Denosumab (3)  ·  Human Growth Hormone (3)  ·  Methotrexate (3)  ·  Sulfasalazine (3)  ·  Teriparatide (3)  ·  Zoledronic Acid (3)  ·  Calcium (2)  ·  Growth Hormone (2)  ·  Meloxicam (2)  ·  Pamidronate (2)

Sponsors

Charite University, Berlin, Germany (10)  ·  Ahmad Jabir Rahyussalim (3)  ·  Shinshu University (3)  ·  Tel-Aviv Sourasky Medical Center (3)  ·  BioSurface Engineering Technologies, Inc (2)  ·  Changchun GeneScience Pharmaceutical Co., Ltd. (2)  ·  University of Aarhus (2)  ·  All Natural Medicine Clinic, LLC (1)  ·  Altus Pharmaceuticals (1)  ·  Ankasa Regenerative Therapeutics, Inc. (1)  ·  Assaf-Harofeh Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azelon Pharmaceuticals (1)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  Biomatlante (1)

Countries

United States (20)  ·  China (15)  ·  Germany (10)  ·  France (4)  ·  Indonesia (4)  ·  Italy (4)  ·  Denmark (3)  ·  India (3)  ·  Iran (3)  ·  Japan (3)  ·  Russia (3)  ·  Taiwan (3)  ·  United Kingdom (3)  ·  Australia (2)  ·  Bangladesh (2)

Top investigators

Joachim Sieper, Prof. (3)  ·  Joachim Sieper, MD (2)  ·  Joachim Sieper, Prof. Dr. (2)  ·  AJ Gelderblom, Prof (1)  ·  Abdalla Awidi (1)  ·  Alex Mullen (1)  ·  Amir Ali Hamidieh, MD (1)  ·  Andi Alfian Zainuddin, MD. Ph.D (1)  ·  Ann Wenzel, professor (1)  ·  Anton Sculean, Prof. (1)  ·  Antonio Casado (1)  ·  Asadul Islam, MBBS (1)  ·  Beniamin Bokhyan, PhD (1)

Results publications

PMID 24476416, PMID 17077737, PMID 18576337, PMID 19830485, PMID 20061334, PMID 20193083, PMID 20461780, PMID 21138567, PMID 21425247, PMID 22289280, PMID 23321647, PMID 23625982, PMID 23686466, PMID 23786760, PMID 24716739, PMID 25028375, PMID 25140041, PMID 25315149, PMID 25568820, PMID 26021713, PMID 27108405, PMID 27206923, PMID 28590796, PMID 29788942, PMID 30355512, PMID 32484386, PMID 32524605, PMID 32678055, PMID 33306625, PMID 33717658, PMID 34717922, PMID 34785545, PMID 36410666, PMID 37269909, PMID 37338608, PMID 37449658, PMID 38737002, PMID 39762123, PMID 40200363, PMID 40686685, PMID 42254059, PMID 42337043

NIH funding

2019 (1), R01AR056651 (1), R21AI058756 (1)